Sandra Janneth Perdomo

Dr. Sandra Janneth Perdomo

Research Vicerrectory, Universidad El Bosque, Bogotá, Colombia
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in EBioMedicine
Verified
Journal Article
Open access
LFLynnette Fernandez-Cuesta
Lynnette Fernandez-Cuesta
Sandra Janneth PerdomoSandra Janneth Perdomo
Sandra Janneth Perdomo
PAPatrice H. Avogbe
Patrice H. Avogbe
NLNoemie Leblay
Noemie Leblay
TDTiffany M. Delhomme
Tiffany M. Delhomme
PBPaul Brennan
Paul Brennan
Circulating tumor DNA (ctDNA) is emerging as a key potential biomarker for post-diagnosis surveillance but it may also play a crucial role in the detection of pre-clinical cancer. Small-cell lung cancer (SCLC) is an excellent candidate for early detection given there are no successful therapeutic options for late-stage disease, and it displays almost universal inactivation of TP53. We assessed the presence of TP53 mutations in the cell-free DNA (cfDNA) extracted from the plasma of 51 SCLC cases and 123 non-cancer controls. We identified mutations using a pipeline specifically designed to accurately detect variants at very low fractions. We detected TP53 mutations in the cfDNA of 49% SCLC patients and 11.4% of non-cancer controls. When stratifying the 51 initial SCLC cases by stage, TP53 mutations were detected in the cfDNA of 35.7% early-stage and 54.1% late-stage SCLC patients. The results in the controls were further replicated in 10.8% of an independent series of 102 non-cancer controls. The detection of TP53 mutations in 11% of the 225 non-cancer controls suggests that somatic mutations in cfDNA among individuals without any cancer diagnosis is a common occurrence, and poses serious challenges for the development of ctDNA screening tests.

8 June 2021 in Nutrition and Cancer
Verified
Journal Article
Closed access
Andres Cardona-MendozaAndres Cardona-Mendoza
Andres Cardona-Mendoza
GOGeovanny Olivares-Niño
Geovanny Olivares-Niño
DDDavid Díaz-Báez
David Díaz-Báez
Gloria Inés LafaurieGloria Inés Lafaurie
Gloria Inés Lafaurie
Sandra Janneth PerdomoSandra Janneth Perdomo
Sandra Janneth Perdomo
Oral cancer (OC) is a multifactorial disease caused by isolated or combined risk factors related to tobacco, alcohol consumption, and human papillomavirus infection. It is an aggressive pathology with a low five-year survival rate after surgery, chemotherapy, and/or radiotherapy, frequently associated with severe side effects. Drugs with the highest anti-tumor effect are obtained from natural products with diverse biological and molecular activities and potential chemopreventive and anticancer properties. This review summarizes the natural products reported to have the chemopreventive and anti-tumor potential for OC treatment, showing that several of these compounds are promising candidates as chemopreventive agents, and those with the highest anti-tumor potential induce apoptosis and inhibit proliferation and metastasis-related processes. For this reason, natural products have the potential to be important preventive and therapeutic options for OC in the future.

1 February 2014 in Gene
Verified
Journal Article
Closed access
IRIrene Rodriguez-Hernandez
Irene Rodriguez-Hernandez
Sandra Janneth PerdomoSandra Janneth Perdomo
Sandra Janneth Perdomo
ASAngel Santos-Briz
Angel Santos-Briz
JGJuan Garcia
Juan Garcia
JGJuan Antonio Gomez-Moreta
Juan Antonio Gomez-Moreta
RSRogelio González Sarmiento
Rogelio González Sarmiento

1 September 2018 in Heliyon
Verified
Journal Article
Open access
NJNury Tatiana Jiménez
Nury Tatiana Jiménez
JMJuan Carlos Munévar
Juan Carlos Munévar
JGJosé Manuel González
José Manuel González
CIClementina Infante
Clementina Infante
Sandra Janneth PerdomoSandra Janneth Perdomo
Sandra Janneth Perdomo
Three-dimensional-porous scaffolds of bone graft substitutes play a critical role in both cell targeting and transplantation strategies. These scaffolds provide surfaces that facilitate the response of stem cells related to attachment, survival, migration, proliferation, and differentiation. The aim of this study was to evaluate the in vitro behavior of human dental pulp mesenchymal stem cells cultured on scaffolds of polylactic/polyglycolic acid with and without hydroxyapatite. We performed an in vitro experimental study using dental pulp stem cells obtained from samples of premolars, molars. The cells were cultured on scaffolds with osteogenic differentiation medium. Cell proliferation, adhesion and cell differentiation to an osteoblastic linage in the biomaterial were evaluated at three different time points: 7, 15 and 30 days. Each experiment was performed in triplicate. Analysis of the data was performed with the Split Plot block and MANOVA model. The differentiation capability of hDPSCs towards the osteoblast lineage was better in the scaffold of PLGA/HA at 7, 15 and 30 days, as indicated by the high expression of osteogenic markers RUNX2, ALP, OPN and COL-I, compared with differentiation in the PLGA scaffold. No statistically significant differences were found in cell adhesion between the two types of scaffolds. The PLGA/HA scaffold provided better physical and chemical signals, as judged by the ability of dental pulp stem cells to adhere, proliferate and differentiate toward the osteogenic lineage.

10 January 2018 in Journal of Investigative and Clinical Dentistry
Verified
Journal Article
Closed access
PDF file
Gloria Inés LafaurieGloria Inés Lafaurie
Gloria Inés Lafaurie
Sandra Janneth PerdomoSandra Janneth Perdomo
Sandra Janneth Perdomo
MBMaría R. Buenahora
María R. Buenahora
SASandra Amaya
Sandra Amaya
DDDavid Díaz-Báez
David Díaz-Báez

6 April 2024 in Molecules
Verified
Journal Article
Open access
PDF file
DBDiana Marcela Buitrago
Diana Marcela Buitrago
Sandra Janneth PerdomoSandra Janneth Perdomo
Sandra Janneth Perdomo
FSFrancisco Arturo Silva
Francisco Arturo Silva
Willy Fernando Cely-VelozaWilly Fernando Cely-Veloza
Willy Fernando Cely-Veloza
Gloria Inés LafaurieGloria Inés Lafaurie
Gloria Inés Lafaurie
Propolis extracts have been widely studied due to their popularity in traditional medicine, presenting incredible biodiversity. This study aimed to analyze propolis extracts’ phytochemical, physicochemical, and biological activities from four different biogeographic zones of the Huila region (Colombia). The raw material samples were collected by the scraping method and the ethanolic extracts (EEPs) were obtained by cold maceration with ethanol (96%). The physicochemical and sensory characterization was carried out according to the protocols recommended by the Brazilian Ministry of Agriculture and the main components of the EEPs were identified by LC-HRMS analysis. The determination of total phenols and flavonoids was carried out using colorimetric techniques. The antioxidant activity, cytotoxicity, and cell cycle regulation analyses in L929 and HGnF cells were evaluated using DPPH, Alamar Blue, and 7-amino actinomycin D (7-AAD) assays. The propolis samples presented an average yield of 33.1%, humidity between 1.6 and 2.8%, melting point between 54 and 62 °C, ashes between 1.40 and 2.19%, and waxes of 6.6–17.9%, respectively. The sensory characteristics of all samples were heterogeneous, complying with the quality specifications established by international standards. The polyphenolic and total flavonoid content was representative in the samples from Quebradon (255.9 ± 9.2 mg GAE/g, 543.1 ± 8.4 mg QE/g) and Arcadia (543.1 ± 8.4 mg GAE/g, 32.5 ± 1.18 g QE/g) (p < 0.05) that correlated with high antioxidant activity (Quebradon: 37.2 ± 1.2 µmol/g, Arcadia: 38.19 ± 0.7 µmol/g). In the chemical composition analysis, 19 compounds were characterized as phenolic acids and flavonoids, the most representative being chrysoeriol-O-methyl-ether, ellagic acid, and 3,4-O-dimethylcaffeic acid. Regarding biological activity, Quebradon and Arcadia propolis presented low toxicity with IC50 of 2.83 ± 2.3 mg/mL and 4.28 ± 1.4 mg/mL in HGnF cells, respectively, and an arrest of the cell cycle in the G2/M phase of 71.6% and 50.8% compared to the control (11.9%) (p < 0.05). In general, the results of this study contribute to the identification of valid quality criteria to evaluate Colombian propolis, contributing to its study and chemical and biological characterization as a source of raw material for industrial and pharmaceutical use. In addition, Quebradon and Arcadia propolis can be important sources of bioactive molecules for the development of new drugs.